title: Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".
authors.affiliation: Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
authors.forename: Lars
authors.initials: L
authors.lastname: Wallentin
authors.forename: Renato D
authors.initials: RD
authors.lastname: Lopes
authors.forename: Michael
authors.initials: M
authors.lastname: Hanna
authors.forename: Laine
authors.initials: L
authors.lastname: Thomas
authors.forename: Anne
authors.initials: A
authors.lastname: Hellkamp
authors.forename: Sunil
authors.initials: S
authors.lastname: Nepal
authors.forename: Elaine M
authors.initials: EM
authors.lastname: Hylek
authors.forename: Sana M
authors.initials: SM
authors.lastname: Al-Khatib
authors.forename: John H
authors.initials: JH
authors.lastname: Alexander
authors.forename: Marco
authors.initials: M
authors.lastname: Alings
authors.forename: John
authors.initials: J
authors.lastname: Amerena
authors.forename: Jack
authors.initials: J
authors.lastname: Ansell
authors.forename: Philip
authors.initials: P
authors.lastname: Aylward
authors.forename: Jozef
authors.initials: J
authors.lastname: Bartunek
authors.forename: Patrick
authors.initials: P
authors.lastname: Commerford
authors.forename: Raffaele
authors.initials: R
authors.lastname: De Caterina
authors.forename: Cetin
authors.initials: C
authors.lastname: Erol
authors.forename: Veli-Pekka
authors.initials: VP
authors.lastname: Harjola
authors.forename: Claes
authors.initials: C
authors.lastname: Held
authors.forename: John
authors.initials: J
authors.lastname: Horowitz
authors.forename: Kurt
authors.initials: K
authors.lastname: Huber
authors.forename: Steen
authors.initials: S
authors.lastname: Husted
authors.forename: Matyas
authors.initials: M
authors.lastname: Keltai
authors.forename: Fernando
authors.initials: F
authors.lastname: Lanas
authors.forename: Liu
authors.initials: L
authors.lastname: Lisheng
authors.forename: John J V
authors.initials: JJ
authors.lastname: McMurray
authors.forename: Byung-Hee
authors.initials: BH
authors.lastname: Oh
authors.forename: Mårten
authors.initials: M
authors.lastname: Rosenqvist
authors.forename: Witold
authors.initials: W
authors.lastname: Ruzyllo
authors.forename: Philippe Gabriel
authors.initials: PG
authors.lastname: Steg
authors.forename: Dragos
authors.initials: D
authors.lastname: Vinereanu
authors.forename: Denis
authors.initials: D
authors.lastname: Xavier
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Granger
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011720:Pyrazoles / Q000008:administration & dosage*; D011728:Pyridones / Q000008:administration & dosage*; D020521:Stroke / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D011720:Pyrazoles; D011728:Pyridones; D014859:Warfarin